GE Healthcare Announces FDA Clearance of MR Systems Optima MR360 and Brivo MR355 to Address Demand for Productivity, Versatility and Value

WAUKESHA, WI MARCH 3, 2011—GE Healthcare, a unit of General Electric Company (NYSE:GE) today announced FDA clearance of Optima™ MR360 1.5 tesla and Brivo™ MR355 1.5 tesla magnetic resonance systems addressing the demand for productivity, versatility and value. Approximately 180 systems have been ordered by hospitals and imaging centers worldwide.

The Optima MR360 is an application-rich 1.5 Tesla MR system that can help improve imaging productivity and help offset ownership costs. It is engineered around a high-definition platform that includes remarkable flexibility and efficiency to deliver benefits on many levels: technologists benefit from ease of use; radiologists benefit from consistent high quality; administrators benefit from satisfied patients, and efficient throughput.

The system delivers outstanding value with the benefits of a GE ecomagination product. Its footprint is 20 percent smaller than other fully body 1.5T systems, and it can consume up to 34 percent less power than previous generation systems, potentially saving up to 60,000 kWh per year.

The Brivo MR355, also recently cleared by the FDA, makes the diagnostic benefits of high-performance MR technology easy and accessible. It combines simplification technology with low total cost of ownership.

Using an uncompromised magnet, the Brivo MR355 features a 48 cm field-of-view. It also features the OpTix technology, and the embedded Express coil.

source: GE Healthcare

No comments: